Perioperative Individualized Goal Directed Therapy for Cardiac Surgery: A Historical-Prospective, Comparative Effectiveness Study
Open Access
- 21 January 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (3) , 400
Abstract
Introduction: Cardiac surgery patients are at increased risk for post-operative complications and prolonged length of stay. Perioperative goal directed therapy (GDT) has demonstrated utility for non-cardiac surgery, however, GDT is not common for cardiac surgery. We initiated a quality improvement (QI) project focusing on the implementation of a GDT protocol, which was applied from the immediate post-bypass period into the intensive care unit (ICU). Our hypothesis was that this novel GDT protocol would decrease ICU length of stay and possibly improve postoperative outcomes. Methods: This was a historical prospective, QI study for patients undergoing cardiac surgery requiring cardiopulmonary bypass (CPB). Integral to the QI project was education towards all associated providers on the concepts related to GDT. The protocol involved identifying patient specific targets for cardiac index and mean arterial pressure. These targets were maintained from the post-CPB period to the first 12 h in the ICU. Statistical comparisons were performed between the year after GDT therapy was launched to the last two years prior to protocol implementation. The primary outcome was ICU length of stay. Results: There was a significant decrease in ICU length of stay when comparing the year after the protocol initiation to years prior, from a median of 6.19 days to 4 days (2017 vs. 2019, p < 0.0001), and a median of 5.88 days to 4 days (2018 vs. 2019, p < 0.0001). Secondary outcomes demonstrated a significant reduction in total administered volumes of inotropic medication(milrinone). All other vasopressors demonstrated no differences across years. Hospital length of stay comparisons did not demonstrate a significant reduction. Conclusion: These results suggest that an individualized goal directed therapy for cardiac surgery patients can reduce ICU length of stay and decrease amount of inotropic therapy.Keywords
Funding Information
- Edwards Lifesciences (investigator initiated study program approval in 2019)
This publication has 29 references indexed in Scilit:
- Clinical review: Goal-directed therapy-what is the evidence in surgical patients? The effect on different risk groupsCritical Care, 2012
- Single transpulmonary thermodilution and continuous monitoring of central venous oxygen saturation during off‐pump coronary surgeryActa Anaesthesiologica Scandinavica, 2009
- Publication guidelines for quality improvement studies in health care: evolution of the SQUIRE projectBMJ, 2009
- The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaborationQuality and Safety in Health Care, 2008
- Comorbidity in patients undergoing coronary artery bypass graft surgery: impact on outcome and implications for cardiac rehabilitationEuropean Journal of Preventive Cardiology, 2008
- Early goal-directed therapy in moderate to high-risk cardiac surgery patientsAnnals of Cardiac Anaesthesia, 2008
- Goal-directed fluid management reduces vasopressor and catecholamine use in cardiac surgery patientsIntensive Care Medicine, 2006
- Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgeryBMJ, 2004
- A Prospective, Randomized Study of Goal-Oriented Hemodynamic Therapy in Cardiac Surgical PatientsAnesthesia & Analgesia, 2000
- Perioperative Plasma Volume Expansion Reduces the Incidence of Gut Mucosal Hypoperfusion During Cardiac SurgeryArchives of Surgery, 1995